Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.
Osteoporos Int
; 27(6): 2099-107, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26879200
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Biphenyl Compounds
/
Bone Density
/
Osteoporosis, Postmenopausal
/
Bone Density Conservation Agents
Type of study:
Clinical_trials
Language:
En
Journal:
Osteoporos Int
Year:
2016
Type:
Article
Affiliation country:
Switzerland